Laboratorios Farmaceuticos Rovi (41L) Financial Statements

0 Followers

Laboratorios Farmaceuticos Rovi Financial Overview

Laboratorios Farmaceuticos Rovi's market cap is currently CHF2.82B. The company's EPS TTM is CHF3.62; its P/E ratio is 16.38; Laboratorios Farmaceuticos Rovi is scheduled to report earnings on July 23, 2026, and the estimated EPS forecast is CHF―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	€ 743.48M	€ 763.75M	€ 829.51M	€ 817.70M	€ 648.68M
Gross Profit	€ 451.65M	€ 478.35M	€ 483.34M	€ 519.61M	€ 384.82M
Operating Income	€ 173.14M	€ 179.54M	€ 220.25M	€ 255.85M	€ 181.57M
EBITDA	€ 203.52M	€ 207.69M	€ 245.81M	€ 281.49M	€ 204.72M
Net Income	€ 140.44M	€ 136.88M	€ 170.34M	€ 199.67M	€ 153.08M
Balance Sheet
Cash & Short-Term Investments	€ 97.98M	€ 27.41M	€ 25.32M	€ 124.94M	€ 99.03M
Total Assets	€ 955.69M	€ 832.02M	€ 799.88M	€ 878.70M	€ 732.68M
Total Debt	€ 121.72M	€ 114.41M	€ 65.43M	€ 72.14M	€ 73.14M
Net Debt	€ 23.75M	€ 87.22M	€ 40.10M	€ -52.81M	€ -25.89M
Total Liabilities	€ 276.79M	€ 250.48M	€ 256.39M	€ 357.32M	€ 261.70M
Stockholders' Equity	€ 664.41M	€ 572.03M	€ 539.39M	€ 520.01M	€ 470.98M
Cash Flow
Free Cash Flow	€ 120.16M	€ 76.06M	€ 58.06M	€ 186.21M	€ 108.50M
Operating Cash Flow	€ 185.37M	€ 138.28M	€ 113.25M	€ 237.60M	€ 149.44M
Investing Cash Flow	€ -67.56M	€ -81.06M	€ -52.03M	€ -57.15M	€ -40.84M
Financing Cash Flow	€ -47.02M	€ -55.36M	€ -160.84M	€ -154.54M	€ -62.73M

Currency in EUR

Laboratorios Farmaceuticos Rovi Earnings and Revenue History

Income Statement >

Laboratorios Farmaceuticos Rovi Debt to Assets

Balance Sheet >

Laboratorios Farmaceuticos Rovi Cash Flow

Cash Flow >

Laboratorios Farmaceuticos Rovi Forecast EPS vs Actual EPS

Earnings >